Position in ACRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,532,797
+$2,998,524 QoQ
Shares Held
2,008,746
+33.3% QoQ
Ownership
1.44%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 25.49929159784263.ToString("F0")%
Shared 0.ToString("F0")%
None 74.50070840215737.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. ACRS ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in ACRS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,532,797 | 2,008,746 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,534,273 | 1,506,403 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,114,977 | 1,113,146 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,429,788 | 1,006,893 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $623,513 | 407,525 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $791,802 | 319,275 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $217,029 | 188,721 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $216,283 | 196,621 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,659,664 | 1,338,439 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,457,860 | 1,388,439 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,703,179 | 1,562,508 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $15,057,074 | 1,451,984 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,514,933 | 1,423,354 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,527,447 | 1,303,330 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $20,509,644 | 1,303,027 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $17,174,164 | 1,230,241 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $18,677,643 | 1,083,390 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,229,050 | 1,047,390 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,046,952 | 1,058,164 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,792,957 | 1,070,214 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,862,138 | 192,942 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $504,918 | 78,040 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $200,562 | 78,040 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $126,424 | 78,040 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $693,875 | 667,188 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||